Differentiating coronavirus disease 2019 (COVID-19) from influenza and dengue
Open Access
- 5 October 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-9
Abstract
The novel coronavirus disease 2019 (COVID-19) presents with non-specific clinical features. This may result in misdiagnosis or delayed diagnosis, and lead to further transmission in the community. We aimed to derive early predictors to differentiate COVID-19 from influenza and dengue. The study comprised 126 patients with COVID-19, 171 with influenza and 180 with dengue, who presented within 5 days of symptom onset. All cases were confirmed by reverse transcriptase polymerase chain reaction tests. We used logistic regression models to identify demographics, clinical characteristics and laboratory markers in classifying COVID-19 versus influenza, and COVID-19 versus dengue. The performance of each model was evaluated using receiver operating characteristic (ROC) curves. Shortness of breath was the strongest predictor in the models for differentiating between COVID-19 and influenza, followed by diarrhoea. Higher lymphocyte count was predictive of COVID-19 versus influenza and versus dengue. In the model for differentiating between COVID-19 and dengue, patients with cough and higher platelet count were at increased odds of COVID-19, while headache, joint pain, skin rash and vomiting/nausea were indicative of dengue. The cross-validated area under the ROC curve for all four models was above 0.85. Clinical features and simple laboratory markers for differentiating COVID-19 from influenza and dengue are identified in this study which can be used by primary care physicians in resource limited settings to determine if further investigations or referrals would be required.Keywords
All Related Versions
Funding Information
- National Medical Research Council, Singapore
This publication has 29 references indexed in Scilit:
- Re-introduction of dengue virus serotype 2 in the state of Rio de Janeiro after almost a decade of epidemiological silencePLOS ONE, 2019
- Update: Influenza Activity in the United States During the 2018–19 Season and Composition of the 2019–20 Influenza VaccineMMWR. Morbidity and Mortality Weekly Report, 2019
- DengueThe Lancet, 2019
- Dengue in Singapore from 2004 to 2016: Cyclical Epidemic Patterns Dominated by Serotypes 1 and 2The American Journal of Tropical Medicine and Hygiene, 2018
- The global burden of dengue: an analysis from the Global Burden of Disease Study 2013The Lancet Infectious Diseases, 2016
- Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and ElaborationAnnals of Internal Medicine, 2015
- Utility of warning signs in guiding admission and predicting severe disease in adult dengueBMC Infectious Diseases, 2013
- The Early Clinical Features of Dengue in Adults: Challenges for Early Clinical DiagnosisPLOS Neglected Tropical Diseases, 2011
- Improving the Clinical Diagnosis of Influenza—a Comparative Analysis of New Influenza A (H1N1) CasesPLOS ONE, 2009
- A comparative investigation of methods for logistic regression with separated or nearly separated dataStatistics in Medicine, 2006